Pfizer CEO says he's prepared to shift manufacturing to the U.S. amid tariff threats
Business
In This Story PFE -1.31% LLY +0.87% Pfizer ( PFE -1.31% ) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals. Suggested Reading Nvidia, Dell, and Super Micro stock tumble as new China probe sparks fears of tighter scrutiny The SEC has emerged as a savior for crypto — a trend never seen before. Here’s what that means Google's Gemini Live will
din zilele anterioare